These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15573865)

  • 1. Selective retinoic acid receptor ligands for rheumatoid arthritis.
    Beehler BC; Brinckerhoff CE; Ostrowski J
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1153-7. PubMed ID: 15573865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications for ligands of retinoid receptors.
    Thacher SM; Vasudevan J; Chandraratna RA
    Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
    Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
    Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element.
    Cohen AJ; Lassová L; Golden EB; Niu Z; Adams SL
    J Cell Biochem; 2006 Sep; 99(1):269-78. PubMed ID: 16598786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic retinoids: recent developments concerning structure and clinical utility.
    Kagechika H; Shudo K
    J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective RXR modulators for the treatment of type II diabetes.
    Faul MM; Grese TA
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids: potential in cancer prevention and therapy.
    Clarke N; Germain P; Altucci L; Gronemeyer H
    Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat.
    Ishikawa J; Sutoh C; Ishikawa A; Kagechika H; Hirano H; Nakamura S
    Eur J Neurosci; 2008 May; 27(9):2363-72. PubMed ID: 18445226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T; Kanayama T
    Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid receptor modulators: a perspective on recent advances and promises.
    Alvarez S; Bourguet W; Gronemeyer H; de Lera AR
    Expert Opin Ther Pat; 2011 Jan; 21(1):55-63. PubMed ID: 21091043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.
    Marchwicka A; Cunningham A; Marcinkowska E; Brown G
    Expert Opin Ther Pat; 2016 Aug; 26(8):957-71. PubMed ID: 27336223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
    Su D; Gudas LJ
    Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids for the treatment of psoriasis: outlook for the future.
    Kuenzli S; Saurat JH
    Curr Opin Investig Drugs; 2001 May; 2(5):625-30. PubMed ID: 11569936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous T-cell lymphoma with retinoids.
    Zhang C; Duvic M
    Dermatol Ther; 2006; 19(5):264-71. PubMed ID: 17014481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and detection of the in vitro agonistic activity of xenobiotics on the retinoic acid receptor.
    Kamata R; Shiraishi F; Nishikawa J; Yonemoto J; Shiraishi H
    Toxicol In Vitro; 2008 Jun; 22(4):1050-61. PubMed ID: 18289828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.